|Institutional Source||Beutler Lab|
|Gene Name||cadherin 5|
|Synonyms||VECD, VEcad, VE-cadherin, CD144, VE-Cad, 7B4/cadherin-5, VEC|
|Is this an essential gene?||Essential (E-score: 1.000)|
|Stock #||R2281 (G1)|
|Chromosomal Location||104101625-104144511 bp(+) (GRCm38)|
|Type of Mutation||missense|
|DNA Base Change (assembly)||A to G at 104125733 bp|
|Amino Acid Change||Glutamic Acid to Glycine at position 160 (E160G)|
|Ref Sequence||ENSEMBL: ENSMUSP00000034339 (fasta)|
|Gene Model||predicted gene model for transcript(s): [ENSMUST00000034339]|
|Predicted Effect||probably damaging
AA Change: E160G
PolyPhen 2 Score 0.998 (Sensitivity: 0.27; Specificity: 0.99)
AA Change: E160G
|Coding Region Coverage||
FUNCTION: This gene encodes a member of the cadherin family of calcium-dependent glycoproteins that mediate cell adhesion and regulate many morphogenetic events during development. The encoded preproprotein is further processed to generate a mature protein. Mice lacking the encoded protein die in utero due to vascular insufficiency, caused by increased endothelial apoptosis. Multiple distinct genes of the cadherin family, including this gene, are found on chromosome 8. [provided by RefSeq, Oct 2015]
PHENOTYPE: Homozygous inactivation or cytosolic truncation of this gene causes embryonic growth retardation, abnormal somite and heart development, impaired remodeling and maturation of endothelial cells, increased endothelial apoptosis and severe vascular defects leading to embryonic death at midgestation. [provided by MGI curators]
|Allele List at MGI|
|Other mutations in this stock||
|Other mutations in Cdh5||
(F):5'- ATCTTCGGGGTCGATGCTAAC -3'
(R):5'- TCAGAGTTTAGCCTTTAGGGAC -3'
(F):5'- ACAGGGAATGTGCTTGCC -3'
(R):5'- GCCTTTAGGGACACATTTTGAAATC -3'